How to Source Metformin + Dapagliflozin Tablets for Pharmaceutical Formulation
Metformin + Dapagliflozin Tablets (Tablets, (dapagliflozin/metformin): 5 mg/500 mg, 5 mg/1000 mg, 10 mg/500 mg, 10 mg/1000 mg) is classified under Diabetes. It is therapeutically aligned with reference brands such as Xigduo XR®(US and EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Metformin + Dapagliflozin Tablets for formulation, R&D, or bulk manufacturing.
Product Overview:
Dapagliflozin/metformin (Xigduo XR) combines two mechanisms: dapagliflozin, an SGLT2 inhibitor, reduces blood glucose by increasing urinary glucose excretion, while metformin decreases hepatic glucose production and improves insulin sensitivity. Benefits include improved glycemic control, weight loss, and reduced cardiovascular risk in type 2 diabetes patients.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Metformin + Dapagliflozin Tablets must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Metformin + Dapagliflozin Tablets is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Conclusion
Sourcing Metformin + Dapagliflozin Tablets is more than procurement—it’s a strategic partnership. With its tablets form and (dapagliflozin/metformin): 5 mg/500 mg, 5 mg/1000 mg, 10 mg/500 mg, 10 mg/1000 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Metformin + Dapagliflozin Tablets.
Frequently Asked Questions For Sourcing of Metformin + Dapagliflozin Tablets
What is the typical lead time for Metformin + Dapagliflozin Tablets?
Lead times range from 4–6 weeks depending on supplier and region.
Is Metformin + Dapagliflozin Tablets available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Metformin + Dapagliflozin Tablets require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Metformin + Dapagliflozin Tablets?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Metformin + Dapagliflozin Tablets?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Metformin + Dapagliflozin Tablets?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Metformin + Dapagliflozin Tablets suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Metformin + Dapagliflozin Tablets be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.